, 1:1000) (Figs 2D-F). Taken together, these experiments suggest that Env-EL9-specific CD8+
Long-term nonprogressive disease among untreated 2, p.33, 2010. ,
, , vol.2, 2010.
Genes regulating HLA class I antigen 60. LLano A FN, Brander C. 2009. How to Optimally Define Optimal Cytotoxic T 38, 1985. ,
HIV transmission. Selection bias at the 1061 heterosexual HIV-1 transmission bottleneck, Science, vol.345, pp.1254031-1062, 2014. ,
Central role of 1065 reverting mutations in HLA associations with human immunodeficiency virus set point, J 1066 Virol, vol.82, pp.8548-8559, 2008. ,
,
Heterogeneity in HIV suppression by CD8 T cells from HIV 1077 controllers: association with Gag-specific CD8 T cell responses, J Immunol, vol.72, pp.7828-1078, 2009. ,
specific cytotoxic responses to HIV type 1 are associated with a decreased risk of 1082 progression to AIDS-related complex or AIDS, AIDS Res Hum Retroviruses, vol.11, p.74 ,
HIV-1 infection: a longitudinal analysis of rapid progressors and long-term 1087 asymptomatics, J Exp Med, vol.181, pp.1365-1372 ,
, , vol.84
How a single patient influenced HIV research, 2014. ,
evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms, J 1143 Virol, vol.71, pp.3120-3128, 1997. ,
Antiviral activity of human 1145 immunodeficiency virus type 1 Gag-specific cytotoxic T lymphocyte targeting is not 1146 necessarily intrinsically superior to envelope targeting, J Virol, vol.85, pp.2474-2478, 1147. ,
Specificity 1168 pockets for the side chains of peptide antigens in HLA-Aw68, Nature, vol.342, p.95, 1989. ,
, , 1991.
, , 2005.
,